Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06270641 · ClinicalTrials.gov registry record · NA

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

A NA study of Fatigue and Physical Inactivity, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT06270641 is a NA study of Fatigue and Physical Inactivity that is actively recruiting participants, run by University of Washington. The registered enrollment target is 106 participants, below the 217-participant average among 109 other Fatigue trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06270641, a NA study of Fatigue and Physical Inactivity, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).

Interventions

  • OTHER ExerciseRx intervention

Study Locations (1)

Washington

  • UW Medicine - Seattle

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2024-02-16
Est. Completion 2026-09-30
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT06270641

The ClinicalTrials.gov registry entry for NCT06270641 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 217-participant average among 109 other Fatigue trials with a reported enrollment target (51% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Fatigue appearing as the primary indexed condition, and to 1 intervention - of which ExerciseRx intervention is the first listed.

NCT06270641 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT06270641 about?

NCT06270641 is a clinical study titled "Increasing Physical Activity for Adults With Multiple Sclerosis (MS)". This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).

What is the current status of trial NCT06270641?

This trial is currently recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2024-02-16. Estimated completion is 2026-09-30.

What conditions does trial NCT06270641 study?

This clinical trial studies the following conditions: Fatigue, Physical Inactivity, Multiple Sclerosis, MS.

What interventions are being tested in trial NCT06270641?

The interventions under investigation include: ExerciseRx intervention (OTHER).

Who is sponsoring clinical trial NCT06270641?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06270641 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fatigue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.